Engineering endogenous l-proline biosynthetic pathway to boost trans-4-hydroxy-l-proline production in Escherichia coli. 2021

Liangzhen Jiang, and Jing Pang, and Lixia Yang, and Wei Li, and Lili Duan, and Guolin Zhang, and Yinggang Luo
Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, 9 Section 4, Renmin Road South, Chengdu 610041, People's Republic of China; College of Pharmacy and Biological Engineering, Chengdu University, 2025 Chengluo Avenue, Chengdu 610106, People's Republic of China.

Non-proteinogenic trans-4-hydroxy-l-proline (t4HYP), a crucial naturally occurred amino acid, is present in most organisms. t4HYP is a regio- and stereo-selectively hydroxylated product of l-proline and a valuable building block for pharmaceutically important intermediates/ingredients synthesis. Microbial production of t4HYP has aroused extensive investigations because of its low-cost and environmentally benign features. Herein, we reported metabolic engineering of endogenous l-proline biosynthetic pathway to enhance t4HYP production in trace l-proline-producing Escherichia coli BL21(DE3) (21-S0). The genes responsible for by-product formation from l-proline, pyruvate, acetyl-CoA, and isocitrate in the biosynthetic network of 21-S0 were knocked out to channel the metabolic flux towards l-proline biosynthesis. PdhR was knocked out to remove its negative regulation and aceK was deleted to ensure isocitrate dehydrogenase's activity and to increase NADPH/NADP+ level. The other genes for l-proline biosynthesis were enhanced by integration of strong promoters and 5'-untranslated regions. The resulting engineered E. coli strains 21-S1 ∼ 21-S9 harboring a codon-optimized proline 4-hydroxylase-encoding gene (P4H) were grown and fermented. A titer of 4.82 g/L of t4HYP production in 21-S6 overexpressing P4H was obtained at conical flask level, comparing with the starting 21-S0 (26 mg/L). The present work paves an efficient metabolic engineering way for higher t4HYP production in E. coli.

UI MeSH Term Description Entries
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000105 Acetyl Coenzyme A Acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent. Acetyl CoA,Acetyl-CoA,CoA, Acetyl,Coenzyme A, Acetyl
D001425 Bacterial Outer Membrane Proteins Proteins isolated from the outer membrane of Gram-negative bacteria. OMP Proteins,Outer Membrane Proteins, Bacterial,Outer Membrane Lipoproteins, Bacterial
D053898 Biosynthetic Pathways Sets of enzymatic reactions occurring in organisms and that form biochemicals by making new covalent bonds. Biosynthetic Pathway,Pathway, Biosynthetic,Pathways, Biosynthetic
D060847 Metabolic Engineering Methods and techniques used to genetically modify cells' biosynthetic product output and develop conditions for growing the cells as BIOREACTORS. Engineering, Metabolic
D029968 Escherichia coli Proteins Proteins obtained from ESCHERICHIA COLI. E coli Proteins

Related Publications

Liangzhen Jiang, and Jing Pang, and Lixia Yang, and Wei Li, and Lili Duan, and Guolin Zhang, and Yinggang Luo
March 2021, Microbial biotechnology,
Liangzhen Jiang, and Jing Pang, and Lixia Yang, and Wei Li, and Lili Duan, and Guolin Zhang, and Yinggang Luo
May 2020, Science advances,
Liangzhen Jiang, and Jing Pang, and Lixia Yang, and Wei Li, and Lili Duan, and Guolin Zhang, and Yinggang Luo
May 2018, Letters in applied microbiology,
Liangzhen Jiang, and Jing Pang, and Lixia Yang, and Wei Li, and Lili Duan, and Guolin Zhang, and Yinggang Luo
October 2018, Journal of bioscience and bioengineering,
Liangzhen Jiang, and Jing Pang, and Lixia Yang, and Wei Li, and Lili Duan, and Guolin Zhang, and Yinggang Luo
December 2019, Bioengineered,
Liangzhen Jiang, and Jing Pang, and Lixia Yang, and Wei Li, and Lili Duan, and Guolin Zhang, and Yinggang Luo
August 2022, Microbial cell factories,
Liangzhen Jiang, and Jing Pang, and Lixia Yang, and Wei Li, and Lili Duan, and Guolin Zhang, and Yinggang Luo
March 2021, Microbial biotechnology,
Liangzhen Jiang, and Jing Pang, and Lixia Yang, and Wei Li, and Lili Duan, and Guolin Zhang, and Yinggang Luo
September 2022, Bioscience, biotechnology, and biochemistry,
Liangzhen Jiang, and Jing Pang, and Lixia Yang, and Wei Li, and Lili Duan, and Guolin Zhang, and Yinggang Luo
April 2021, Microbial cell factories,
Liangzhen Jiang, and Jing Pang, and Lixia Yang, and Wei Li, and Lili Duan, and Guolin Zhang, and Yinggang Luo
April 2000, Bioscience, biotechnology, and biochemistry,
Copied contents to your clipboard!